vimarsana.com

Latest Breaking News On - Bio stock down - Page 3 : vimarsana.com

HC Wainwright Comments on Annovis Bio, Inc s Q1 2025 Earnings (NYSE:ANVS)

Annovis Bio, Inc. (NYSE:ANVS – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for Annovis Bio in a report issued on Tuesday, April 2nd. HC Wainwright analyst R. Selvaraju anticipates that the company will post earnings of ($0.48) per share for the quarter. HC Wainwright has a […]

JPMorgan Chase & Co Trims AnaptysBio (NASDAQ:ANAB) Target Price to $28 00

JPMorgan Chase & Co Trims AnaptysBio (NASDAQ:ANAB) Target Price to $28 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Generation Bio Co (NASDAQ:GBIO) Sees Significant Decline in Short Interest

Generation Bio Co (NASDAQ:GBIO) Sees Significant Decline in Short Interest
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Generation Bio Co (NASDAQ:GBIO) Sees Significant Decline in Short Interest

Generation Bio Co (NASDAQ:GBIO) Sees Significant Decline in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cabaletta Bio (NASDAQ:CABA) Given New $35 00 Price Target at Wells Fargo & Company

Cabaletta Bio (NASDAQ:CABA – Free Report) had its target price raised by Wells Fargo & Company from $34.00 to $35.00 in a report issued on Friday, Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other research analysts also recently commented on the stock. Morgan Stanley reduced their price […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.